Moffitt CEO Dr. Alan List awarded Celgene 2016 Career Achievement Award for Clinical Research in Hematology

December 12, 2016

Dr. Alan List wins career achievement award

TAMPA, Fla. — Moffitt Cancer Center President and CEO Alan F. List, M.D., has been awarded the Celgene 2016 Career Achievement Award for Clinical Research in Hematology. The award recognizes List for his tremendous impact and significant contributions in the field of clinical hematology throughout his career. The Celgene Corporation will provide a $25,000 grant to Moffitt in List’s name in honor of the award.

Moffitt medical oncologist Eric Padron, M.D., nominated List for the award.

“I am honored to accept this award, especially in Moffitt’s 30th anniversary year,” said List. “It has been inspiring to work at an institution that places such a high value on collaboration. This award really reflects a team of people who are truly driven to find a cure for cancer.”

Celgene is a global biopharmaceutical company working toward delivering innovative and life-changing drugs to patients worldwide. The Career Achievement Award, as well as the Young Investigator Award and Future Leaders in Hematology Award, are an extension of Celgene’s mission to develop and support investigators who seek to advance knowledge in the field of hematology.

List holds several positions at Moffitt. Other than serving as president and CEO, he is a member of the Department of Malignant Hematology and the Experimental Therapeutics Program and a professor of internal medicine and oncology at the University of South Florida. List and his research team have contributed to understanding the biology of acute myeloid leukemia and myelodysplastic syndromes to develop more effective treatment strategies and are nationally recognized for their efforts.

The recognition from Celgene is among several notable awards received by List and Moffitt in 2016. List was named to Becker’s Hospital Review’s 110 Physician Leaders of Hospitals and Health Systems in both 2015 and 2016. In the summer of 2016, Moffitt was ranked No. 6 on DiversityInc’s 2016 Top 10 Hospitals and Health Systems list, and was designated a Leader in LGBT Healthcare Equality by the Human Rights Campaign. Moffitt was also ranked No. 6 on U.S. News & World Report’s 2016 Best Hospitals for Cancer rankings.

Celgene Corporation hosted the award presentation on Dec. 3 in San Diego to honor List and the other 2016 award recipients. 

About Moffitt Cancer Center
Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 47 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, clinical trials, prevention and cancer control. Moffitt is the No. 6 cancer hospital in the nation and has been listed in U.S. News & World Report as one of the “Best Hospitals” for cancer care since 1999. Moffitt devotes more than 2.5 million square feet to research and patient care. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 5,200 team members, Moffitt has an economic impact in the state of $2.1 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, Twitter and YouTube

###